Riptide rebrands itself to reflect focus on futureRiptide Technologies is changing its name to Avreo, a variant of the Greek “avrio” meaning “tomorrow.” The New Orleans-based firm made this move to emphasize its concentration
Riptide Technologies is changing its name to Avreo, a variant of the Greek avrio meaning tomorrow. The New Orleans-based firm made this move to emphasize its concentration on developing data-management solutions based on emerging technologies. Avreo launched version 1.0 of its XML-based system ARIIS (advanced radiology image and information system) in October (HNN 9/20/00) and is currently gearing up for the RSNA meeting in November.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.